|
Characteristics
|
N (%)
|
Irisin levels (μg/ml)
|
p-value
|
|---|
|
Tumor size (cm)
| | |
0.084
|
|
≤2.0
|
43 (48.3 %)
|
2.34 ± 0.52
| |
|
2.1–5.0
|
31 (34.8 %)
|
2.58 ± 0.59
| |
|
>5.0
|
15 (16.9 %)
|
2.65 ± 0.57
| |
|
Grade
| | |
0.450
|
|
I
|
14 (14.3 %)
|
2.35 ± 0.59
| |
|
II
|
29 (29.6 %)
|
2.42 ± 0.59
| |
|
III
|
55 (56.1 %)
|
2.54 ± 0.56
| |
|
Stage
| | |
0.039
|
|
I
|
21 (30.4 %)
|
2.31 ± 0.54
| |
|
II
|
28 (40.6 %)
|
2.52 ± 0.58
| |
|
III
|
20 (29.0 %)
|
2.75 ± 0.50a
| |
|
Lymph nodes
| | |
0.098
|
|
Negative
|
40 (56.3 %)
|
2.44 ± 0.58
| |
|
Positive
|
31 (43.7 %)
|
2.66 ± 0.53
| |
|
Concurrent DCIS
| | |
0.161
|
|
No
|
34 (34.0 %)
|
2.37 ± 0.58
| |
|
Yes
|
66 (66.0 %)
|
2.54 ± 0.56
| |
|
ER status
| | |
0.966
|
|
Negative
|
24 (25.3 %)
|
2.46 ± 0.58
| |
|
Positive
|
71 (74.7 %)
|
2.46 ± 0.56
| |
|
PR status
| | |
0.904
|
|
Negative
|
30 (29.7 %)
|
2.47 ± 0.57
| |
|
Positive
|
65 (68.4 %)
|
2.46 ± 0.57
| |
|
c-erb-B2 status
| | |
0.226
|
|
Negative
|
64 (68.1 %)
|
2.41 ± 0.52
| |
|
Positive
|
30 (31.9 %)
|
2.56 ± 0.66
| |
|
Ki67 Value
| | |
0.243
|
|
<10 %
|
23 (24.5 %)
|
2.27 ± 0.54
| |
|
10–15 %
|
16 (17.0 %)
|
2.53 ± 0.67
| |
|
16–30 %
|
25 (26.6 %)
|
2.58 ± 0.54
| |
|
>30 %
|
30 (31.9 %)
|
2.49 ± 0.53
| |
|
P53 status
| | |
0.759
|
|
<10 %
|
52 (57.8 %)
|
2.45 ± 0.55
| |
|
>10 %
|
38 (42.2 %)
|
2.49 ± 0.57
| |
- Data are presented as mean ± standard deviation
- acompared to stage I after Bonferroni correction for multiple comparisons
